Y
Yugeesh R Lankadeva
Researcher at Florey Institute of Neuroscience and Mental Health
Publications - 60
Citations - 1692
Yugeesh R Lankadeva is an academic researcher from Florey Institute of Neuroscience and Mental Health. The author has contributed to research in topics: Acute kidney injury & Renal blood flow. The author has an hindex of 17, co-authored 48 publications receiving 1089 citations. Previous affiliations of Yugeesh R Lankadeva include Monash University, Clayton campus & University of Melbourne.
Papers
More filters
Journal ArticleDOI
Acute kidney injury in sepsis.
Rinaldo Bellomo,John A. Kellum,Claudio Ronco,Ron Wald,Ron Wald,Johan Mårtensson,Matthew J Maiden,Matthew J Maiden,Sean M. Bagshaw,Neil J Glassford,Neil J Glassford,Yugeesh R Lankadeva,Suvi T. Vaara,Antoine G. Schneider +13 more
TL;DR: In this paper, the optimal intensity of renal replacement therapy has been established, while the timing of when to commence RRT is now a focus of investigation, as well as when to start RRT in patients with septic AKI.
Journal ArticleDOI
Intrarenal and urinary oxygenation during norepinephrine resuscitation in ovine septic acute kidney injury
Yugeesh R Lankadeva,Junko Kosaka,Roger G. Evans,Simon R. Bailey,Rinaldo Bellomo,Clive N. May +5 more
TL;DR: In this article, the authors examined renal cortical, medullary, and urinary oxygenation in ovine septic acute kidney injury and the response to resuscitation with norepinephrine.
Journal ArticleDOI
Sepsis-induced acute kidney injury: A disease of the microcirculation
Shuai Ma,Shuai Ma,Roger G. Evans,Naoya Iguchi,Naoya Iguchi,Marianne Tare,Helena C. Parkington,Rinaldo Bellomo,Clive N. May,Yugeesh R Lankadeva +9 more
TL;DR: Recent progress made in understanding how vasopressin, angiotensin II, and, paradoxically, α2‐adrenergic receptor agonists (clonidine and dexmedetomidine) may be feasible adjunct therapies for catecholamine‐resistant vasodilatory shock is outlined.
Journal ArticleDOI
Urinary Oxygenation as a Surrogate Measure of Medullary Oxygenation During Angiotensin II Therapy in Septic Acute Kidney Injury.
TL;DR: In septic acute kidney injury, angiotensin II appears to be a safe, effective therapy, and urinary PO2 may be used to detect medullary hypoxia, which was characterized by hypotension and a 60% ± 6% decrease in creatinine clearance.
Journal ArticleDOI
Renal haemodynamics and oxygenation during and after cardiac surgery and cardiopulmonary bypass.
Roger G. Evans,Yugeesh R Lankadeva,Andrew D. Cochrane,Bruno Marino,Naoya Iguchi,Michael Z.L. Zhu,Sally G Hood,Julian A. Smith,Rinaldo Bellomo,Bruce S. Gardiner,Bruce S. Gardiner,Chang Joon Lee,Chang Joon Lee,David Smith,Clive N. May +14 more
TL;DR: A multi‐disciplinary pathway for translation comprising three components is proposed, large‐animal models of CPB to continuously monitor both whole kidney and regional kidney perfusion and oxygenation and clinically feasible non‐invasive methods to continuously Monitor renal oxygenation in the operating theatre and to identify patients at risk of AKI.